Haitao Zhao

Shenyang Pharmaceutical University — China

Medicine · Health Sciences

58h-index14.6kcitations542works8.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cholangiocarcinoma and Gallbladder Cancer Studies(126), Hepatocellular Carcinoma Treatment and Prognosis(103), Cancer Immunotherapy and Biomarkers(63), Pancreatic and Hepatic Oncology Research(61), Liver Disease Diagnosis and Treatment(43)

Publications541 total

Phishing Email Detection Using Large Language Models
ArXiv.org·2025Open Access
Rescue of extreme hepatectomy mice by primary hepatocyte-derived 3D bio-printed organ transplantation
Biofabrication·2025Open Access
Clinical outcomes of combined transarterial chemoembolization and microwave ablation for hepatic hemangiomas: a comparative analysis of large versus. giant tumors
BMC Gastroenterology·2025Open Access
High-dosage human albumin infusion may be superior for hypervolemic hyponatremia in cirrhosis with ascites
Expert Review of Gastroenterology & Hepatology·2025
FAD synthase confers ferroptosis resistance and restrains CD8+ T cell recruitment in hepatocellular carcinoma
Nature Communications·2025· 1 citedOpen Access
Dynamic urinary proteomics integrates single-cell and spatial transcriptomics to reveal tumour microenvironment and predict immunotherapy response in biliary tract cancer
Gut·2025· 1 cited
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
The Lancet·2025· 8 cited
Local therapy overcomes primary resistance to target-immunotherapy combination in unresectable hepatocellular carcinoma
Cancer Immunology Immunotherapy·2025· 1 citedOpen Access
Rapid thrombogenesis prediction in COVID-19 patients using DNN with data labeling
Scientific Reports·2025Open Access
Immunotherapy change overcomes acquired resistance after chemo-immunotherapy in unresectable biliary tract cancer
Cancer Immunology Immunotherapy·2025Open Access
[Analysis of gene detection results of next-generation sequencing of liquid based cytological specimens of lung adenocarcinoma cavity effusion and evaluation of clinical efficacy].
PubMed·2025
Current status of management of immune-related adverse events and practical needs for oncologist education
Cancer Biology and Medicine·2025Open Access
PAFAH1B3 Exists in Linear Chromosomal and Extrachromosomal Circular DNA and Promotes HCC Progression via EMT
International Journal of Molecular Sciences·2025Open Access
Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study
Journal of Hepatocellular Carcinoma·2025· 2 citedOpen Access
1506P Phase I study of IPM001 injection in advanced hepatocellular carcinoma: Safety, tolerability, and preliminary efficacy
Annals of Oncology·2025
The landscape of research on B cell and immunotherapy in solid tumors over the past 20 years
Discover Oncology·2025· 1 citedOpen Access
Immunotherapy in biliary tract cancer: reshaping the tumour microenvironment and advancing precision combination strategies
Frontiers in Immunology·2025· 1 citedOpen Access
Gut microbiota and metabolite signatures predict severe immune-related adverse events in advanced hepatobiliary cancers
Journal of Advanced Research·2025Open Access
Local–regional therapy combined with immune checkpoint inhibitors and lenvatinib versus immune checkpoint inhibitors plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter cohort study
Cancer Immunology Immunotherapy·2025Open Access
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of laryngeal mucosa-associated lymphoid tissue lymphoma
Endoscopy·2025Open Access
page 1 of 28Next →

Frequent Co-authors

Xinting Sang(19), Xiaobo Yang(17), Jianzhen Lin(16), Junyu Long(14), Yi Bai(12), Anqiang Wang(11), Yilei Mao(11), Dongxu Wang(10), Ruoyu Miao(8), Xueshuai Wan(8), Huayu Yang(7), Yi Zhao(6), Haohai Zhang(6), Xu Yang(5), Xin Lu(5), Yiyao Xu(5), Shouxian Zhong(5), Jin‐Song Bian(5), Li Huo(5), Liangcai Wu(5)